330 related articles for article (PubMed ID: 30654452)
1. Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity.
Ruoß M; Damm G; Vosough M; Ehret L; Grom-Baumgarten C; Petkov M; Naddalin S; Ladurner R; Seehofer D; Nussler A; Sajadian S
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654452
[TBL] [Abstract][Full Text] [Related]
2. Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7.
Sajadian SO; Tripura C; Samani FS; Ruoss M; Dooley S; Baharvand H; Nussler AK
Clin Epigenetics; 2016; 8():46. PubMed ID: 27134688
[TBL] [Abstract][Full Text] [Related]
3. Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines.
Kvist AJ; Kanebratt KP; Walentinsson A; Palmgren H; O'Hara M; Björkbom A; Andersson LC; Ahlqvist M; Andersson TB
Biochem Pharmacol; 2018 Sep; 155():124-140. PubMed ID: 29953844
[TBL] [Abstract][Full Text] [Related]
4. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
Schulz C; Kammerer S; Küpper JH
Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
[TBL] [Abstract][Full Text] [Related]
5. Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between Snail and HNF4α during liver stem cell malignant transformation.
Huang Q; Pu M; Zhao G; Dai B; Bian Z; Tang H; Chen C; Liu W; Qu X; Shen L; Tao K
Cancer Lett; 2017 Aug; 402():52-60. PubMed ID: 28536011
[TBL] [Abstract][Full Text] [Related]
6. Optimizing combination of liver-enriched transcription factors and nuclear receptors simultaneously favors ammonia and drug metabolism in liver cells.
Su Y; Chen Z; Yan L; Lian F; You J; Wang X; Tang N
Exp Cell Res; 2018 Jan; 362(2):504-514. PubMed ID: 29253535
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S
Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism.
Lin J; Schyschka L; Mühl-Benninghaus R; Neumann J; Hao L; Nussler N; Dooley S; Liu L; Stöckle U; Nussler AK; Ehnert S
Arch Toxicol; 2012 Jan; 86(1):87-95. PubMed ID: 21735230
[TBL] [Abstract][Full Text] [Related]
9. The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers.
Yao D; Peng S; Dai C
BMC Cancer; 2013 Sep; 13():432. PubMed ID: 24059685
[TBL] [Abstract][Full Text] [Related]
10. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
11. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
[TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.
Karaosmanoğlu O; Banerjee S; Sivas H
Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962
[TBL] [Abstract][Full Text] [Related]
13. The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells.
Cipriano M; Correia JC; Camões SP; Oliveira NG; Cruz P; Cruz H; Castro M; Ruas JL; Santos JM; Miranda JP
Arch Toxicol; 2017 Jun; 91(6):2469-2489. PubMed ID: 27909741
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells.
Rodríguez-Antona C; Donato MT; Boobis A; Edwards RJ; Watts PS; Castell JV; Gómez-Lechón MJ
Xenobiotica; 2002 Jun; 32(6):505-20. PubMed ID: 12160483
[TBL] [Abstract][Full Text] [Related]
15. CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
Wattanavanitchakorn S; Rojvirat P; Chavalit T; MacDonald MJ; Jitrapakdee S
PLoS One; 2018; 13(3):e0194252. PubMed ID: 29566023
[TBL] [Abstract][Full Text] [Related]
16. Cell lines: a tool for in vitro drug metabolism studies.
Donato MT; Lahoz A; Castell JV; Gómez-Lechón MJ
Curr Drug Metab; 2008 Jan; 9(1):1-11. PubMed ID: 18220566
[TBL] [Abstract][Full Text] [Related]
17. YAP integrates the regulatory Snail/HNF4α circuitry controlling epithelial/hepatocyte differentiation.
Noce V; Battistelli C; Cozzolino AM; Consalvi V; Cicchini C; Strippoli R; Tripodi M; Marchetti A; Amicone L
Cell Death Dis; 2019 Oct; 10(10):768. PubMed ID: 31601778
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of cytochrome p450 genes by the nuclear receptor hepatocyte nuclear factor 4-alpha.
Jover R; Moya M; Gómez-Lechón MJ
Curr Drug Metab; 2009 Jun; 10(5):508-19. PubMed ID: 19689247
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-561 promotes acetaminophen-induced hepatotoxicity in HepG2 cells and primary human hepatocytes through downregulation of the nuclear receptor corepressor dosage-sensitive sex-reversal adrenal hypoplasia congenital critical region on the X chromosome, gene 1 (DAX-1).
Li M; Yang Y; He ZX; Zhou ZW; Yang T; Guo P; Zhang X; Zhou SF
Drug Metab Dispos; 2014 Jan; 42(1):44-61. PubMed ID: 24104199
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatocyte nuclear factor 1 and 4 alpha (HNF1α and HNF4α) as a mechanism of arsenic carcinogenesis.
Pastoret A; Marcos R; Sampayo-Reyes A; Saucedo-Cardenas O; Lozano-Garza GH; Hernandez A
Arch Toxicol; 2013 Jun; 87(6):1001-12. PubMed ID: 23052196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
